Sign In

Login

Password

Forgot Password ? Sign Up

Serotonin (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Serotonin" in German language version.

refsWebsite
Global rank German rank
80nih.gov
4th place
7th place
48doi.org
2nd place
3rd place
1sigmaaldrich.com
924th place
87th place
1mpg.de
1,624th place
377th place
1embl.de
low place
low place
1web.archive.org
1st place
1st place
1scribd.com
482nd place
762nd place
1archive.org
6th place
40th place
1duden.de
804th place
44th place

archive.org

  • A. Huxley, C. Palmer, M. Horowitz: Moksha: Writings on Psychedelics and the Visionary Experience (1931–1963). Stonehill, New York 1977, ISBN 0-88373-042-1, S. 107. (TO DR. HUMPHRY OSMOND [smith 744] )archive.org

doi.org

  • K. E. Hamlin, F. E. Fischer: The synthesis of 5-hydroxytryptamine. In: J. Am. Chem. Soc. Band 73, Nr. 10, 1951, S. 5007–5008, doi:10.1021/ja01154a551.
  • T. Herraiz: Tetrahydro-beta-carbolines, potential neuroactive alkaloids, in chocolate and cocoa. In: Journal of Agricultural and Food Chemistry. Band 48, Nr. 10, Oktober 2000, S. 4900–4904, doi:10.1021/jf000508l, PMID 11052752 (englisch).
  • D. L. Chase, M. R. Koelle: Biogenic amine neurotransmitters in C. elegans. In: WormBook. 2007, S. 1–15, doi:10.1895/wormbook.1.132.1, PMID 18050501 (englisch).
  • D. Y. Kim, M. Camilleri: Serotonin: a mediator of the brain-gut connection. In: Am. J. Gastroenterol. Band 95, Nr. 10, Oktober 2000, S. 2698–2709, doi:10.1111/j.1572-0241.2000.03177.x, PMID 11051338.
  • A. Ek, B. Witkop: The Synthesis of Labile Hydroxytryptophan Metabolites. In: J. Am. Chem. Soc. Band 76, Nr. 22, 1954, S. 5579–5588, doi:10.1021/ja01651a001.
  • R. Majiama, M. Kotake: Synthetische Versuche in der Indol-Gruppe, VI.: Eine neue Synthese von β-Indolyl-alkylaminen. In: Chem. Ber. Band 58, 1925, S. 2042–2046, doi:10.1002/cber.19250580917.
  • M. E. Speeter, R. V. Heinzelmann, D. I. Weisblatt: The synthesis of the blood serum vasoconstrictor principle serotonin creatinine sulfate. In: J. Am. Chem. Soc. Band 73, Nr. 11, 1951, S. 5514–5515, doi:10.1021/ja01155a580.
  • K. H. Matzke, G. J. Meyer, A. Osterholz, G. Coates, G. Firnau: Synthesis of 11C-labeled 5-hydroxytryptamine for the measurement of pulmonary endothelial cell function. In: International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes. Band 42, Nr. 4, 1991, S. 401–404, doi:10.1016/0883-2889(91)90145-Q.
  • W. E. Noland, R. A. Hovden: A new synthesis of serotonin. In: J. Org. Chem. Band 24, Nr. 6, 1959, S. 894–895, doi:10.1021/jo01088a632.
  • E. H. P. Young: The synthesis of 5-hydroxytryptamine (serotonin) and related tryptamines. In: J. Chem. Soc. 1958, S. 3493–3496, doi:10.1039/JR9580003493.
  • M. E. Speeter, W. C. Anthony: THE ACTION OF OXALYL CHLORIDE ON INDOLES: A NEW APPROACH TO TRYPTAMINES. In: J. Am. Chem. Soc. Band 76, Nr. 23, 1954, S. 6208–6210, doi:10.1021/ja01652a113.
  • John Harley-Mason, A. H. Jackson: Hydroxytryptamines. Part I. Bufotenine, 6-hydroxybufotenine, and serotonin. In: J. Chem. Soc. 1954, S. 1165–1171, doi:10.1039/JR9540001165.
  • R. A. Abramovitch, D. Shapiro: Tryptamines, carbolines, and related compounds. Part II. A convenient synthesis of tryptamines and β-carbolines. In: J. Chem. Soc. 1956, S. 4589, doi:10.1039/JR9560004589.
  • G. Revial, I. Jabin, S. Lim, M. Pfau: Aromatization of 1,6,7,7a-Tetrahydro-2H-indol-2-ones by a Novel Process. Preparation of Key-Intermediate Methyl 1-Benzyl-5-methoxy-1H-indole-3-acetate and the Syntheses of Serotonin, Melatonin, and Bufotenin. In: J. Org. Chem. Band 67, Nr. 7, 2002, S. 2252–2256, doi:10.1021/jo0110597.
  • D. C. Klein: Arylalkylamine N-acetyltransferase: „the Timezyme“. In: J. Biol. Chem. Band 282, Nr. 7, Februar 2007, S. 4233–4237, doi:10.1074/jbc.R600036200, PMID 17164235.
  • M. J. Millan, P. Marin, J. Bockaert, C. M. la Cour: Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions. In: Trends in Pharmacological Sciences. Band 29, Nr. 9, September 2008, S. 454–464, doi:10.1016/j.tips.2008.06.007, PMID 18676031 (englisch).
  • Diego J. Walther, Jens-Uwe Peter, Sandra Winter, Markus Höltje, Nils Paulmann, Maik Grohmann, Jakob Vowinckel, Victor Alamo-Bethencourt, Claudia S. Wilhelm, Gudrun Ahnert-Hilger, Michael Bader: Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release. In: Cell. Band 115, Nr. 7, Dezember 2003, S. 851–862, doi:10.1016/S0092-8674(03)01014-6, PMID 14697203 (englisch).
  • C. Ullmer, K. Schmuck, H. O. Kalkman, H. Lübbert: Expression of serotonin receptor mRNAs in blood vessels. In: FEBS Letters. Band 370, Nr. 3, August 1995, S. 215–221, doi:10.1016/0014-5793(95)00828-W, PMID 7656980 (englisch).
  • M. D. Gershon: Review article: serotonin receptors and transporters – roles in normal and abnormal gastrointestinal motility. In: Aliment. Pharmacol. Ther. 20 Suppl 7, November 2004, S. 3–14, doi:10.1111/j.1365-2036.2004.02180.x, PMID 15521849.
  • M. M. Costedio, N. Hyman, G. M. Mawe: Serotonin and its role in colonic function and in gastrointestinal disorders. In: Dis. Colon Rectum. Band 50, Nr. 3, März 2007, S. 376–388, doi:10.1007/s10350-006-0763-3, PMID 17195902.
  • T. Braun, P. Voland, L. Kunz, C. Prinz, M. Gratzl: Enterochromaffin cells of the human gut: sensors for spices and odorants. In: Gastroenterology. Band 132, Nr. 5, Mai 2007, S. 1890–1901, doi:10.1053/j.gastro.2007.02.036, PMID 17484882.
  • C. Costagliola, F. Parmeggiani, F. Semeraro, A. Sebastiani: Selective serotonin reuptake inhibitors: a review of its effects on intraocular pressure. In: Curr Neuropharmacol. Band 6, Nr. 4, Dezember 2008, S. 293–310, doi:10.2174/157015908787386104, PMID 19587851, PMC 2701282 (freier Volltext).
  • R. J. Nelson, B. C. Trainor: Neural mechanisms of aggression. In: Nature Reviews Neuroscience. Band 8, Nr. 7, Juli 2007, S. 536–546, doi:10.1038/nrn2174, PMID 17585306 (englisch, pdf (Memento vom 11. Februar 2014 im Internet Archive)).
  • D. E. Nichols: Hallucinogens. In: Pharmacology & Therapeutics. Band 101, Nr. 2, Februar 2004, S. 131–181, doi:10.1016/j.pharmthera.2003.11.002, PMID 14761703 (englisch).
  • M. Jouvet: Sleep and serotonin: an unfinished story. In: Neuropsychopharmacology. Band 21, 2 Suppl, August 1999, S. 24S–27S, doi:10.1016/S0893-133X(99)00009-3, PMID 10432485 (englisch).
  • J. M. Monti: The role of dorsal raphe nucleus serotonergic and non-serotonergic neurons, and of their receptors, in regulating waking and rapid eye movement (REM) sleep. In: Sleep Med Rev. Band 14, Nr. 5, Oktober 2010, S. 319–327, doi:10.1016/j.smrv.2009.10.003, PMID 20153670.
  • J. M. Monti, H. Jantos: The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking. In: Prog. Brain Res. Band 172, 2008, S. 625–646, doi:10.1016/S0079-6123(08)00929-1, PMID 18772053.
  • E. M. Hull, J. W. Muschamp, S. Sato: Dopamine and serotonin: influences on male sexual behavior. In: Physiology & Behavior. Band 83, Nr. 2, November 2004, S. 291–307, doi:10.1016/j.physbeh.2004.08.018, PMID 15488546 (englisch).
  • Yan Liu, Yun’ai Jiang u. a.: Molecular regulation of sexual preference revealed by genetic studies of 5-HT in the brains of male mice. In: Nature. Band 472, 2011, S. 95, doi:10.1038/nature09822.
  • Mariana Angoa-Pérez, Nieves Herrera-Mundo u. a.: Brain Serotonin Signaling Does Not Determine Sexual Preference in Male Mice. In: PLOS ONE. Band 10, 2015, Artikel e0118603, doi:10.1371/journal.pone.0118603.
  • M. Druce, A. Rockall, A. B. Grossman: Fibrosis and carcinoid syndrome: from causation to future therapy. In: Nature Reviews Endocrinology. Band 5, Nr. 5, Mai 2009, S. 276–283, doi:10.1038/nrendo.2009.51, PMID 19444261.
  • M. R. Maclean, Y. Dempsie: The serotonin hypothesis of pulmonary hypertension revisited. In: Adv. Exp. Med. Biol. Band 661, 2010, S. 309–322, doi:10.1007/978-1-60761-500-2_20, PMID 20204739.
  • E. Hamel: Serotonin and migraine: biology and clinical implications. In: Cephalalgia. Band 27, Nr. 11, November 2007, S. 1293–1300, doi:10.1111/j.1468-2982.2007.01476.x, PMID 17970989.
  • J. J. Mann: Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior. In: Neuropsychopharmacology. Band 21, 2 Suppl, August 1999, S. 99S–105S, doi:10.1016/S0893-133X(99)00040-8, PMID 10432495.
  • J. R. Lacasse, J. Leo: Serotonin and depression: a disconnect between the advertisements and the scientific literature. In: PLoS Med. Band 2, Nr. 12, Dezember 2005, Artikel e392, doi:10.1371/journal.pmed.0020392, PMID 16268734, PMC 1277931 (freier Volltext).
  • E. H. Turner, J. M. Loftis, A. D. Blackwell: Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan. In: Pharmacol. Ther. Band 109, Nr. 3, März 2006, S. 325–338, doi:10.1016/j.pharmthera.2005.06.004, PMID 16023217.
  • H. E. Bays: Lorcaserin and adiposopathy: 5-HT2c agonism as a treatment for ‘sick fat’ and metabolic disease. In: Expert Rev Cardiovasc Ther. Band 7, Nr. 11, November 2009, S. 1429–1445, doi:10.1586/erc.09.123, PMID 19900026.
  • T. Nagatomo, M. Rashid, H. Abul Muntasir, T. Komiyama: Functions of 5-HT2A receptor and its antagonists in the cardiovascular system. In: Pharmacology & Therapeutics. Band 104, Nr. 1, Oktober 2004, S. 59–81, doi:10.1016/j.pharmthera.2004.08.005, PMID 15500909 (englisch).
  • A. Billio, E. Morello, M. J. Clarke: Serotonin receptor antagonists for highly emetogenic chemotherapy in adults. In: Cochrane Database Syst Rev. Nr. 1, 2010, S. CD006272, doi:10.1002/14651858.CD006272.pub2, PMID 20091591.
  • C. C. Apfel, P. Kranke, S. Piper u. a.: Übelkeit und Erbrechen in der postoperativen Phase. Experten- und evidenzbasierte Empfehlungen zu Prophylaxe und Therapie. In: Anaesthesist. Band 56, Nr. 11, November 2007, S. 1170–1180, doi:10.1007/s00101-007-1210-0, PMID 17726590.
  • A. Rex, B. Bert, H. Fink: Pharmakologie der 5-HT3-Antagonisten. In: Pharm Unserer Zeit. Band 36, Nr. 5, 2007, S. 342–353, doi:10.1002/pauz.200700230, PMID 17722161.
  • E. A. Mayer, S. Bradesi: Alosetron and irritable bowel syndrome. In: Expert Opin Pharmacother. Band 4, Nr. 11, November 2003, S. 2089–2098, doi:10.1517/14656566.4.11.2089, PMID 14596662.
  • D. E. Nichols: Differences Between the Mechanism of Action of Mdma, Mbdb, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens. In: Journal of Psychoactive Drugs. Band 18, Nr. 4, 1986, S. 305–313 (englisch; online auf scribd.com; doi:10.1080/02791072.1986.10472362).
  • D. E. Nichols: Hallucinogens. In: Pharmacology & therapeutics. Band 101, Nummer 2, Februar 2004, S. 131–181, doi:10.1016/j.pharmthera.2003.11.002. PMID 14761703 (Review).
  • Thomas S. Ray, Olivier Jacques Manzoni: Psychedelics and the Human Receptorome. In: PLoS ONE. Band 5, 2010, S. e9019, doi:10.1371/journal.pone.0009019.
  • C. S. Grob, A. L. Danforth, G. S. Chopra, M. Hagerty, C. R. McKay, A. L. Halberstadt, G. R. Greer: Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. In: Archives of general psychiatry. Band 68, Nummer 1, Januar 2011, S. 71–78, doi:10.1001/archgenpsychiatry.2010.116. PMID 20819978.
  • K. W. Tupper, E. Wood, R. Yensen, M. W. Johnson: Psychedelic medicine: a re-emerging therapeutic paradigm. In: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. Band 187, Nummer 14, Oktober 2015, S. 1054–1059, doi:10.1503/cmaj.141124. PMID 26350908, PMC 4592297 (freier Volltext) (Review)
  • Therapeutic advances in psychopharmacology. Band 4, Nummer 4, August 2014, S. 156–169, doi:10.1177/2045125314527985. PMID 25083275, PMC 4104707 (freier Volltext) (Review).

duden.de

embl.de

eggnog.embl.de

mpg.de

vlp.mpiwg-berlin.mpg.de

  • C. Ludwig, A. Schmidt: Das Verhalten der Gase, welche mit dem Blut durch den reizbaren Säugethiermuskel strömen. In: Arbeiten aus der Physiologischen Anstalt zu Leipzig. 1868, S. 1–61 (Online).

nih.gov

ncbi.nlm.nih.gov

  • M. M. Rapport, A. A. Green, I. H. Page: Serum vasoconstrictor, serotonin; isolation and characterization. In: Journal of Biological Chemistry. Band 176, Nr. 3, Dezember 1948, S. 1243–1251, PMID 18100415 (englisch).
  • M. M. Rapport: Serum vasoconstrictor (serotonin) the presence of creatinine in the complex; a proposed structure of the vasoconstrictor principle. In: Journal of Biological Chemistry. Band 180, Nr. 3, Oktober 1949, S. 961–969, PMID 18139191 (englisch).
  • V. Erspamer, B. Asero: Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine. In: Nature. Band 169, Nr. 4306, Mai 1952, S. 800–801, PMID 14941051 (englisch).
  • B. M. Twarog, I. H. Page: Serotonin content of some mammalian tissues and urine and a method for its determination. In: American Journal of Physiology. Band 175, Nr. 1, Oktober 1953, S. 157–161, PMID 13114371 (englisch).
  • J. H. Gaddum, Z. P. Picarelli: Two kinds of tryptamine receptor. In: British Journal of Pharmacology and Chemotherapy. Band 12, Nr. 3, September 1957, S. 323–328, PMID 13460238, PMC 1509685 (freier Volltext) – (englisch).
  • S. J. Peroutka: 5-Hydroxytryptamine receptors in vertebrates and invertebrates: why are there so many? In: Neurochemistry International. Band 25, Nr. 6, Dezember 1994, S. 533–536, PMID 7894329 (englisch).
  • J. M. Feldman, E. M. Lee: Serotonin content of foods: effect on urinary excretion of 5-hydroxyindoleacetic acid. In: American Journal of Clinical Nutrition. Band 42, Nr. 4, Oktober 1985, S. 639–643, PMID 2413754 (englisch).
  • K. McGowan, A. Kane, N. Asarkof, J. Wicks, V. Guerina, J. Kellum, S. Baron, A. R. Gintzler, M. Donowitz: Entamoeba histolytica causes intestinal secretion: role of serotonin. In: Science. Band 221, Nr. 4612, August 1983, S. 762–764, PMID 6308760 (englisch).
  • K. Kang, S. Kang, K. Lee, M. Park, K. Back: Enzymatic features of serotonin biosynthetic enzymes and serotonin biosynthesis in plants. In: Plant Signaling & Behavior. Band 3, Nr. 6, Juni 2008, S. 389–390, PMID 19704574, PMC 2634310 (freier Volltext) – (englisch).
  • B. Muszyńska, K. Sułkowska-Ziaja, H. Ekiert: Indole compounds in fruiting bodies of some selected Macromycetes species and in their mycelia cultured in vitro. In: Pharmazie. Band 64, Nr. 7, Juli 2009, S. 479–480, PMID 19694188 (englisch).
  • T. Herraiz: Tetrahydro-beta-carbolines, potential neuroactive alkaloids, in chocolate and cocoa. In: Journal of Agricultural and Food Chemistry. Band 48, Nr. 10, Oktober 2000, S. 4900–4904, doi:10.1021/jf000508l, PMID 11052752 (englisch).
  • P. Schröder, C. Abele, P. Gohr, U. Stuhlfauth-Roisch, W. Grosse: Latest on enzymology of serotonin biosynthesis in walnut seeds. In: Advances in Experimental Medicine and Biology. Band 467, 1999, S. 637–644, PMID 10721112 (englisch).
  • E. Tanaka, C. Tanaka, N. Mori, Y. Kuwahara, M. Tsuda: Phenylpropanoid amides of serotonin accumulate in witches’ broom diseased bamboo. In: Phytochemistry. Band 64, Nr. 5, November 2003, S. 965–969, PMID 14561512.
  • D. L. Chase, M. R. Koelle: Biogenic amine neurotransmitters in C. elegans. In: WormBook. 2007, S. 1–15, doi:10.1895/wormbook.1.132.1, PMID 18050501 (englisch).
  • S. J. Peroutka, T. A. Howell: The molecular evolution of G protein-coupled receptors: focus on 5-hydroxytryptamine receptors. In: Neuropharmacology. Band 33, Nr. 3–4, 1994, S. 319–324, PMID 7984268.
  • J. Chauveau, V. Fert, A. M. Morel, M. A. Delaage: Rapid and specific enzyme immunoassay of serotonin. In: Clin. Chem. Band 37, Nr. 7, Juli 1991, S. 1178–1184, PMID 1855288.
  • E. Flachaire, C. Beney, A. Berthier, J. Salandre, C. Quincy, B. Renaud: Determination of reference values for serotonin concentration in platelets of healthy newborns, children, adults, and elderly subjects by HPLC with electrochemical detection. In: Clin. Chem. Band 36, Nr. 12, Oktober 1990, S. 2117–2120, PMID 2253357.
  • D. Y. Kim, M. Camilleri: Serotonin: a mediator of the brain-gut connection. In: Am. J. Gastroenterol. Band 95, Nr. 10, Oktober 2000, S. 2698–2709, doi:10.1111/j.1572-0241.2000.03177.x, PMID 11051338.
  • E. P. Benditt, R. L. Wong, M. Arase, E. Roeper: 5-Hydroxytryptamine in mast cells. In: Proc. Soc. Exp. Biol. Med. Band 90, Nr. 1, Oktober 1955, S. 303–304, PMID 13273431.
  • H. Tamir, T. C. Theoharides, M. D. Gershon, P. W. Askenase: Serotonin storage pools in basophil leukemia and mast cells: characterization of two types of serotonin binding protein and radioautographic analysis of the intracellular distribution of [3H]serotonin. In: J. Cell Biol. Band 93, Nr. 3, Juni 1982, S. 638–647, PMID 7118996, PMC 2112151 (freier Volltext).
  • I. M. Modlin, M. Kidd, I. Latich, M. N. Zikusoka, M. D. Shapiro: Current status of gastrointestinal carcinoids. In: Gastroenterology. Band 128, Nr. 6, Mai 2005, S. 1717–1751, PMID 15887161.
  • M. Somei, F. Yamada, T. Kurauchi u. a.: The chemistry of indoles. CIII. Simple syntheses of serotonin, N-methylserotonin, bufotenine, 5-methoxy-N-methyltryptamine, bufobutanoic acid, N-(indol-3-yl)methyl-5-methoxy-N-methyltryptamine, and lespedamine based on 1-hydroxyindole chemistry. In: Chem. Pharm. Bull. Band 49, Nr. 1, Januar 2001, S. 87–96, PMID 11201232.
  • A. Feldstein, H. Hoagland, K. K. Wong, M. R. Oktem, H. Freeman: MAO activity in relation to depression. In: Am J Psychiatry. Band 120, Juni 1964, S. 1192–1194, PMID 14154756.
  • A. Helander, T. Wikström, C. Löwenmo, G. Jacobsson, O. Beck: Urinary excretion of 5-hydroxyindole-3-acetic acid and 5-hydroxytryptophol after oral loading with serotonin. In: Life Sci. Band 50, Nr. 17, 1992, S. 1207–1213, PMID 1373788.
  • D. C. Klein: Arylalkylamine N-acetyltransferase: „the Timezyme“. In: J. Biol. Chem. Band 282, Nr. 7, Februar 2007, S. 4233–4237, doi:10.1074/jbc.R600036200, PMID 17164235.
  • M. J. Millan, P. Marin, J. Bockaert, C. M. la Cour: Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions. In: Trends in Pharmacological Sciences. Band 29, Nr. 9, September 2008, S. 454–464, doi:10.1016/j.tips.2008.06.007, PMID 18676031 (englisch).
  • Diego J. Walther, Jens-Uwe Peter, Sandra Winter, Markus Höltje, Nils Paulmann, Maik Grohmann, Jakob Vowinckel, Victor Alamo-Bethencourt, Claudia S. Wilhelm, Gudrun Ahnert-Hilger, Michael Bader: Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release. In: Cell. Band 115, Nr. 7, Dezember 2003, S. 851–862, doi:10.1016/S0092-8674(03)01014-6, PMID 14697203 (englisch).
  • P. R. Saxena, A. Lawang: A comparison of cardiovascular and smooth muscle effects of 5-hydroxytryptamine and 5-carboxamidotryptamine, a selective agonist of 5-HT1 receptors. In: Archives Internationales de Pharmacodynamie et de Therapie. Band 277, Nr. 2, Oktober 1985, S. 235–252, PMID 2933009 (englisch).
  • C. Ullmer, K. Schmuck, H. O. Kalkman, H. Lübbert: Expression of serotonin receptor mRNAs in blood vessels. In: FEBS Letters. Band 370, Nr. 3, August 1995, S. 215–221, doi:10.1016/0014-5793(95)00828-W, PMID 7656980 (englisch).
  • A. G. Ramage, C. M. Villalón: 5-hydroxytryptamine and cardiovascular regulation. In: Trends in Pharmacological Sciences. Band 29, Nr. 9, September 2008, S. 472–481, PMID 19086344 (englisch).
  • M. D. Gershon: Review article: serotonin receptors and transporters – roles in normal and abnormal gastrointestinal motility. In: Aliment. Pharmacol. Ther. 20 Suppl 7, November 2004, S. 3–14, doi:10.1111/j.1365-2036.2004.02180.x, PMID 15521849.
  • M. M. Costedio, N. Hyman, G. M. Mawe: Serotonin and its role in colonic function and in gastrointestinal disorders. In: Dis. Colon Rectum. Band 50, Nr. 3, März 2007, S. 376–388, doi:10.1007/s10350-006-0763-3, PMID 17195902.
  • E. Bülbring, A. Crema: The release of 5-hydroxytryptamine in relation to pressure exerted on the intestinal mucosa. In: J. Physiol. (Lond.). Band 146, Nr. 1, April 1959, S. 18–28, PMID 13655213, PMC 1356887 (freier Volltext).
  • M. D. Gershon: Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel. In: Aliment. Pharmacol. Ther. 13 Suppl 2, Mai 1999, S. 15–30, PMID 10429737.
  • T. Braun, P. Voland, L. Kunz, C. Prinz, M. Gratzl: Enterochromaffin cells of the human gut: sensors for spices and odorants. In: Gastroenterology. Band 132, Nr. 5, Mai 2007, S. 1890–1901, doi:10.1053/j.gastro.2007.02.036, PMID 17484882.
  • M. Minami, T. Endo, M. Hirafuji u.-a.: Pharmacological aspects of anticancer drug-induced emesis with emphasis on serotonin release and vagal nerve activity. In: Pharmacol Ther. Band 99, Nr. 2, August 2003, S. 149–165, PMID 12888110.
  • C. Costagliola, F. Parmeggiani, F. Semeraro, A. Sebastiani: Selective serotonin reuptake inhibitors: a review of its effects on intraocular pressure. In: Curr Neuropharmacol. Band 6, Nr. 4, Dezember 2008, S. 293–310, doi:10.2174/157015908787386104, PMID 19587851, PMC 2701282 (freier Volltext).
  • N. A. Sharif: Serotonin-2 receptor agonists as novel ocular hypotensive agents and their cellular and molecular mechanisms of action. In: Curr Drug Targets. Band 11, Nr. 8, August 2010, S. 978–993, PMID 20426763.
  • L. Descarries, M. A. Audet, G. Doucet, S. Garcia, S. Oleskevich, P. Séguéla, J. J. Soghomonian, K. C. Watkins: Morphology of central serotonin neurons. Brief review of quantified aspects of their distribution and ultrastructural relationships. In: Annals of the New York Academy of Sciences. Band 600, 1990, S. 81–92, PMID 2252339 (englisch).
  • R. J. Nelson, B. C. Trainor: Neural mechanisms of aggression. In: Nature Reviews Neuroscience. Band 8, Nr. 7, Juli 2007, S. 536–546, doi:10.1038/nrn2174, PMID 17585306 (englisch, pdf (Memento vom 11. Februar 2014 im Internet Archive)).
  • D. E. Nichols: Hallucinogens. In: Pharmacology & Therapeutics. Band 101, Nr. 2, Februar 2004, S. 131–181, doi:10.1016/j.pharmthera.2003.11.002, PMID 14761703 (englisch).
  • M. Jouvet: Sleep and serotonin: an unfinished story. In: Neuropsychopharmacology. Band 21, 2 Suppl, August 1999, S. 24S–27S, doi:10.1016/S0893-133X(99)00009-3, PMID 10432485 (englisch).
  • J. M. Monti: The role of dorsal raphe nucleus serotonergic and non-serotonergic neurons, and of their receptors, in regulating waking and rapid eye movement (REM) sleep. In: Sleep Med Rev. Band 14, Nr. 5, Oktober 2010, S. 319–327, doi:10.1016/j.smrv.2009.10.003, PMID 20153670.
  • J. M. Monti, H. Jantos: The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking. In: Prog. Brain Res. Band 172, 2008, S. 625–646, doi:10.1016/S0079-6123(08)00929-1, PMID 18772053.
  • L. P. Morin: Serotonin and the regulation of mammalian circadian rhythmicity. In: Ann. Med. Band 31, Nr. 1, Februar 1999, S. 12–33, PMID 10219711.
  • R. J. Wurtman, J. J. Wurtman: Brain serotonin, carbohydrate-craving, obesity and depression. In: Obesity Research. 3 Suppl 4, November 1995, S. 477S–480S, PMID 8697046 (englisch).
  • E. M. Hull, J. W. Muschamp, S. Sato: Dopamine and serotonin: influences on male sexual behavior. In: Physiology & Behavior. Band 83, Nr. 2, November 2004, S. 291–307, doi:10.1016/j.physbeh.2004.08.018, PMID 15488546 (englisch).
  • M. D. Waldinger, B. Olivier: Selective serotonin reuptake inhibitor-induced sexual dysfunction: clinical and research considerations. In: International Clinical Psychopharmacology. 13 Suppl 6, Juli 1998, S. S27–33, PMID 9728672 (englisch).
  • R. D. Myers: Serotonin and thermoregulation: old and new views. In: Journal of Physiology (Paris). Band 77, Nr. 2-3, 1981, S. 505–513, PMID 6793718 (englisch).
  • P. B. Hedlund, J. G. Sutcliffe: Functional, molecular and pharmacological advances in 5-HT7 receptor research. In: Trends in Pharmacological Sciences. Band 25, Nr. 9, September 2004, S. 481–486, PMID 15559250 (englisch).
  • M. Druce, A. Rockall, A. B. Grossman: Fibrosis and carcinoid syndrome: from causation to future therapy. In: Nature Reviews Endocrinology. Band 5, Nr. 5, Mai 2009, S. 276–283, doi:10.1038/nrendo.2009.51, PMID 19444261.
  • M. R. Maclean, Y. Dempsie: The serotonin hypothesis of pulmonary hypertension revisited. In: Adv. Exp. Med. Biol. Band 661, 2010, S. 309–322, doi:10.1007/978-1-60761-500-2_20, PMID 20204739.
  • S. Eddahibi, N. Morrell, M. P. d’Ortho, R. Naeije, S. Adnot: Pathobiology of pulmonary arterial hypertension. In: Eur. Respir. J. Band 20, Nr. 6, Dezember 2002, S. 1559–1572, PMID 12503718.
  • J. M. Esteve, J. M. Launay, O. Kellermann, L. Maroteaux: Functions of serotonin in hypoxic pulmonary vascular remodeling. In: Cell Biochem. Biophys. Band 47, Nr. 1, 2007, S. 33–44, PMID 17406058.
  • E. Hamel: Serotonin and migraine: biology and clinical implications. In: Cephalalgia. Band 27, Nr. 11, November 2007, S. 1293–1300, doi:10.1111/j.1468-2982.2007.01476.x, PMID 17970989.
  • A. J. Coppen: Biochemical aspects of depression. In: Int Psychiatry Clin. Band 6, Nr. 2, 1969, S. 53–81, PMID 5817856.
  • I. P. Lapin, G. F. Oxenkrug: Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect. In: Lancet. Band 1, Nr. 7586, Januar 1969, S. 132–136, PMID 4178247.
  • S. J. Dencker, U. Malm, B. E. Roos, B. Werdinius: Acid monoamine metabolites of cerebrospinal fluid in mental depression and mania. In: J. Neurochem. Band 13, Nr. 12, Dezember 1966, S. 1545–1548, PMID 5962034.
  • J. Mendels, A. Frazer, R. G. Fitzgerald, T. A. Ramsey, J. W. Stokes: Biogenic amine metabolites in cerebrospinal fluid of depressed and manic patients. In: Science. Band 175, Nr. 28, März 1972, S. 1380–1382, PMID 5059569.
  • J. J. Mann: Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior. In: Neuropsychopharmacology. Band 21, 2 Suppl, August 1999, S. 99S–105S, doi:10.1016/S0893-133X(99)00040-8, PMID 10432495.
  • B. Shopsin, E. Friedman, S. Gershon: Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients. In: Arch. Gen. Psychiatry. Band 33, Nr. 7, Juli 1976, S. 811–819, PMID 133650.
  • J. R. Lacasse, J. Leo: Serotonin and depression: a disconnect between the advertisements and the scientific literature. In: PLoS Med. Band 2, Nr. 12, Dezember 2005, Artikel e392, doi:10.1371/journal.pmed.0020392, PMID 16268734, PMC 1277931 (freier Volltext).
  • H. Y. Meltzer: Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia. In: Psychopharmacology. 99 Suppl, 1989, S. S18–27, PMID 2682729 (englisch).
  • G. Curzon: How reserpine and chlorpromazine act: the impact of key discoveries on the history of psychopharmacology. In: Trends Pharmacol. Sci. Band 11, Nr. 2, Februar 1990, S. 61–63, PMID 2180160.
  • E. H. Turner, J. M. Loftis, A. D. Blackwell: Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan. In: Pharmacol. Ther. Band 109, Nr. 3, März 2006, S. 325–338, doi:10.1016/j.pharmthera.2005.06.004, PMID 16023217.
  • H. E. Bays: Lorcaserin and adiposopathy: 5-HT2c agonism as a treatment for ‘sick fat’ and metabolic disease. In: Expert Rev Cardiovasc Ther. Band 7, Nr. 11, November 2009, S. 1429–1445, doi:10.1586/erc.09.123, PMID 19900026.
  • G. Curzon, E. L. Gibson, A. O. Oluyomi: Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability. In: Trends Pharmacol. Sci. Band 18, Nr. 1, Januar 1997, S. 21–25, PMID 9114726.
  • P. A. van Zwieten, G. J. Blauw, P. van Brummelen: Pharmacological profile of antihypertensive drugs with serotonin receptor and alpha-adrenoceptor activity. In: Drugs. 40 Suppl 4, 1990, S. 1–8; discussion 28–30, PMID 1982649 (englisch).
  • T. Nagatomo, M. Rashid, H. Abul Muntasir, T. Komiyama: Functions of 5-HT2A receptor and its antagonists in the cardiovascular system. In: Pharmacology & Therapeutics. Band 104, Nr. 1, Oktober 2004, S. 59–81, doi:10.1016/j.pharmthera.2004.08.005, PMID 15500909 (englisch).
  • A. Billio, E. Morello, M. J. Clarke: Serotonin receptor antagonists for highly emetogenic chemotherapy in adults. In: Cochrane Database Syst Rev. Nr. 1, 2010, S. CD006272, doi:10.1002/14651858.CD006272.pub2, PMID 20091591.
  • C. C. Apfel, P. Kranke, S. Piper u. a.: Übelkeit und Erbrechen in der postoperativen Phase. Experten- und evidenzbasierte Empfehlungen zu Prophylaxe und Therapie. In: Anaesthesist. Band 56, Nr. 11, November 2007, S. 1170–1180, doi:10.1007/s00101-007-1210-0, PMID 17726590.
  • A. Rex, B. Bert, H. Fink: Pharmakologie der 5-HT3-Antagonisten. In: Pharm Unserer Zeit. Band 36, Nr. 5, 2007, S. 342–353, doi:10.1002/pauz.200700230, PMID 17722161.
  • E. A. Mayer, S. Bradesi: Alosetron and irritable bowel syndrome. In: Expert Opin Pharmacother. Band 4, Nr. 11, November 2003, S. 2089–2098, doi:10.1517/14656566.4.11.2089, PMID 14596662.
  • R. B. Rothman, M. H. Baumann: Therapeutic and adverse actions of serotonin transporter substrates. In: Pharm. Ther. Bd. 95, 2002, S. 73–88. PMID 12163129.
  • D. E. Nichols: Hallucinogens. In: Pharmacology & therapeutics. Band 101, Nummer 2, Februar 2004, S. 131–181, doi:10.1016/j.pharmthera.2003.11.002. PMID 14761703 (Review).
  • C. S. Grob, A. L. Danforth, G. S. Chopra, M. Hagerty, C. R. McKay, A. L. Halberstadt, G. R. Greer: Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. In: Archives of general psychiatry. Band 68, Nummer 1, Januar 2011, S. 71–78, doi:10.1001/archgenpsychiatry.2010.116. PMID 20819978.
  • K. W. Tupper, E. Wood, R. Yensen, M. W. Johnson: Psychedelic medicine: a re-emerging therapeutic paradigm. In: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. Band 187, Nummer 14, Oktober 2015, S. 1054–1059, doi:10.1503/cmaj.141124. PMID 26350908, PMC 4592297 (freier Volltext) (Review)
  • Therapeutic advances in psychopharmacology. Band 4, Nummer 4, August 2014, S. 156–169, doi:10.1177/2045125314527985. PMID 25083275, PMC 4104707 (freier Volltext) (Review).

chem.nlm.nih.gov

pubchem.ncbi.nlm.nih.gov

scribd.com

de.scribd.com

  • D. E. Nichols: Differences Between the Mechanism of Action of Mdma, Mbdb, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens. In: Journal of Psychoactive Drugs. Band 18, Nr. 4, 1986, S. 305–313 (englisch; online auf scribd.com; doi:10.1080/02791072.1986.10472362).

sigmaaldrich.com

web.archive.org

  • R. J. Nelson, B. C. Trainor: Neural mechanisms of aggression. In: Nature Reviews Neuroscience. Band 8, Nr. 7, Juli 2007, S. 536–546, doi:10.1038/nrn2174, PMID 17585306 (englisch, pdf (Memento vom 11. Februar 2014 im Internet Archive)).